Evaluation of Costa Rica’s Drug Policy (2005-2025)
This study is part of the COPOLAD III Programme, within Working Group 1.4 on Drug Policy Evaluation, in close collaboration ...
This study is part of the COPOLAD III Programme, within Working Group 1.4 on Drug Policy Evaluation, in close collaboration ...
On Thursday, 13 November, the Costa Rican Drug Institute (ICD) presented the main findings and recommendations on the evaluation of ...
Implementing wastewater studies in Latin America and the Caribbean is the focus of an EUDA technical meeting kicking off from ...
This week professionals from different Cuban organisations have participated in a first workshop on the role of a National Drug ...
On Thursday 25 July 2024, the National Agenda of Research Priorities in Mental Health and Addictions was launched, developed with ...
From October 23-27, 2023, the European Monitoring Centre for Drugs (EMCDDA), in the framework of COPOLAD, organized, together with the ...
What institutional, human and financial resources do the National Drug Observatories have at their disposal to consolidate their national research ...
Responses to the drug problem should place special emphasis on its impact on poverty and marginalization, implementing policies and actions ...
Developing a national drug research agenda presents several challenges, such as the need to use diverse methods to support the ...
The international meeting of National Drug Observatories (NDOs) held within the framework of the emblematic EMCDDA, the European Monitoring Centre ...
COPOLAD is a consortium formed by:


Collaborating partners:


© COPOLAD. Programa de Cooperación entre América Latina, el Caribe y la Unión Europea en Políticas sobre Drogas.